Guardant Health IncGH
ASignal's systematic analysis rates GH as Neutral.
Reflects the latest available analysis · analyzed Aug 22, 2026
The case on GH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (44.3% YoY)
- High gross margin (65.01%) indicating pricing power
- Positive and expanding MACD histogram
- Price above 20-day and 50-day moving averages
- Current ratio of 4.03x suggests strong liquidity position
- Free cash flow positive at $26.61M
- Negative operating cash flow ($-185.19M)
- Negative profit and operating margins (around -38%)
- Highly negative forward P/E (-379.20x) and EV/EBITDA (-54.69x)
- Price near upper Bollinger Band, suggesting potential overextension
- Low Reddit retail interest (only 1 mention)
- Negative return on assets (-18.07%)
See the full verdict on GH
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes GH
Most investors never get a second opinion, let alone several. ASignal runs GH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.